Guardant Health Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
2,506
- Stock Symbol
-
GH
- Investments
-
8
- Share Price
-
$154.86
- (As of Thursday Closing)
Guardant Health General Information
Description
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Contact Information
Website
www.guardanthealth.comCorporate Office
- 3100 Hanover Street
- Palo Alto, CA 94304
- United States
Corporate Office
- 3100 Hanover Street
- Palo Alto, CA 94304
- United States
Guardant Health Timeline
Guardant Health Stock Performance
As of 12-Nov-2026, Guardant Health’s stock price is $154.86. Its current market cap is $21B with 135M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $154.86 | $154.78 | $74.55 - $191.05 | $21B | 135M | 2.04M | -$3.68 |
Guardant Health Financials Summary
As of 30-Sep-2026, Guardant Health has a trailing 12-month revenue of $1.28B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 24,578,773 | 14,011,736 | 4,114,939 | 3,486,855 |
| Revenue | 1,278,884 | 982,021 | 739,016 | 563,948 |
| EBITDA | (482,582) | (408,002) | (443,812) | (468,670) |
| Net Income | (485,073) | (416,277) | (436,373) | (479,449) |
| Total Assets | 1,885,642 | 2,013,659 | 1,485,609 | 1,786,421 |
| Total Debt | 1,691,434 | 1,710,142 | 1,336,052 | 1,353,764 |
Guardant Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Guardant Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Guardant Health Comparisons
Industry
Financing
Details
Guardant Health Competitors (23)
One of Guardant Health’s 23 competitors is Exact Sciences, a Formerly VC-backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Exact Sciences | Formerly VC-backed | Madison, WI | ||||
| Castle Biosciences | Formerly VC-backed | Friendswood, TX | ||||
| Myriad Genetics | Corporation | Salt Lake City, UT | ||||
| Biodesix | Formerly VC-backed | Louisville, CO | ||||
| BioReference Health | Corporate Backed or Acquired | Elmwood Park, NJ |
Guardant Health Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Guardant Health Patents
Guardant Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231781-A1 | Machine learning models using fragmentomics based features for germline somatic discrimination | Pending | 30-Apr-2025 | ||
| WO-2026227069-A1 | Methods and systems for predicting response, monitoring, and optimizing cdk4/6 inhibitor therapy using epigenetic methylation biomarkers | Pending | 25-Apr-2025 | ||
| WO-2026222487-A1 | Methods and compositions for detecting and characterizing drug toxicity in lung | Pending | 18-Apr-2025 | ||
| WO-2026222411-A1 | Methods and compositions for determining and monitoring cancer subtyping evolution | Pending | 17-Apr-2025 | ||
| US-20260331221-A1 | Methods and compositions for cancer subtyping using integrated genomic and epigenomic signatures | Pending | 16-Apr-2025 | G16B20/20 |
Guardant Health Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Guardant Health Investments & Acquisitions (8)
Guardant Health’s most recent deal was a Merger/Acquisition with MetaSight for . The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MetaSight | 01-Dec-2025 | Merger/Acquisition | Other Devices and Supplies | ||
| ObvioHealth | 25-Jul-2024 | Later Stage VC | Other Healthcare Technology Systems | ||
| Guardant Health AMEA | 13-Jun-2022 | Merger/Acquisition | Diagnostic Equipment | ||
| Lunit | 19-Jul-2021 | Later Stage VC | Decision/Risk Analysis | ||
| Whiterabbit.ai | 25-Jun-2021 | Early Stage VC | Decision/Risk Analysis |
Guardant Health ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
20.88 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Services
Subindustry
of 97
Rank
Percentile
Guardant Health Exits (1)
Guardant Health’s most recent exit was on 19-Jul-2021 from Lunit. The exit was categorized as with 10 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Lunit | 19-Jul-2021 | Completed |
|
Guardant Health Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Guardant Health AMEA | Singapore, Singapore | 2012 |
Guardant Health FAQs
-
When was Guardant Health founded?
Guardant Health was founded in 2011.
-
Where is Guardant Health headquartered?
Guardant Health is headquartered in Palo Alto, CA.
-
What is the size of Guardant Health?
Guardant Health has 2,506 total employees.
-
What industry is Guardant Health in?
Guardant Health’s primary industry is Diagnostic Equipment.
-
Is Guardant Health a private or public company?
Guardant Health is a Public company.
-
What is Guardant Health’s stock symbol?
The ticker symbol for Guardant Health is GH.
-
What is the current stock price of Guardant Health?
As of 12-Nov-2026 the stock price of Guardant Health is $154.86.
-
What is the current market cap of Guardant Health?
The current market capitalization of Guardant Health is $21B.
-
What is Guardant Health’s current revenue?
The trailing twelve month revenue for Guardant Health is $1.28B.
-
Who are Guardant Health’s competitors?
Exact Sciences, Castle Biosciences, Myriad Genetics, Biodesix, and BioReference Health are some of the 23 competitors of Guardant Health.
-
What is Guardant Health’s annual earnings per share (EPS)?
Guardant Health’s EPS for 12 months was -$3.68.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
